Abstract
Although nitric oxide (NO) release seems to be influenced by changes in blood pressure, it remains controversial whether its production is or is not affected in hypertension. Recent research work is unraveling profound differences in the role of NO in different forms of hypertension. This role seems to vary depending on the stage of the disease and model studied. In human hypertension, pharmacological experiments revealed an impaired NO dilator mechanism. In spontaneous and renovascular hypertension in the rat, the production of NO is increased, probably as a compensatory mechanism. However, in genetic hypertension, NO is ineffective in performing its biological functions, presumably because of increased inactivation by oxidative radicals. In this form of hypertension, an increased production of contractile factors and/or a decreased release of hyperpolarizing factors seem to be involved. NO also plays a crucial role in the kidney, where it contributes to the regulation of blood pressure. A reduced renal production of NO, even with a normal overall endothelial function, could contribute to the genesis of hypertension. In salt-dependent hypertension (Dahl-and DOCA salt-sensitive), NO production is impaired, probably due to a deficiency of the substrate for NO synthase. In pulmonary hypertension, the use of NO gas inhalation has been proposed as a future therapy for this condition. The above issues will be the focus of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moncada, S. and Higgs, A. Mechanisms of disease. The L-arginine nitric oxide pathway.N. Engl. J. Med. 329(27), 2002–2012 (1993).
Moncada, S. The L arginine: Nitric oxide pathway.Acta Physiol. Scand. 145201–227 (1992).
Nishida, K., Harrison, D.G., Navas, J.P., Fisher, A.A., Dockery, S.P., Uematsu, M., Nerem, R.M., Alexander, W., and Murphy T.J. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.J. Clin. Invest. 902092–2096 (1992).
Schmidt, H.H.H.W., Zernikow, B., Baeblich, S., and Böhme, E. Basal and stimulated formation and release of L arginine derived nitrogen oxides from cultured endothelial cells.J. Pharmacol. Exp. Ther. 254(2), 591–597 (1990).
Weiner, C.P., Lizasoain, I., Baylis, S.A., Knowles, R.G., Charles, I.C., and Moncada S. Induction of calcium dependent nitric oxide synthase by sex hormones.Proc. Natl. Acad. Sci. USA 915212–5216 (1994).
Rees, D.D., Palmer, R.M.J., and Moncada, S. Role of endothelium derived nitric oxide in the regulation of blood pressure.Proc. Natl. Acad. Sci. USA 863375–3378 (1989).
Valiance, P., Collier, J., and Moncada, S. Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet ii, 997–1000 (1989).
Radomski, M.W., Palmer, R.M.J., and Moncada, S. An L arginine to nitric oxide pathway in human platelets regulates aggregation.Proc. Natl. Acad. Sci. USA 875193–5197 (1990).
Nava, E., Leone, A.M., Wiklund, N.P., and Moncada, S. Detection of release of nitric oxide by vasoactive substances in the anaesthesized rat. In: The Biology of Nitric Oxide; Eds. Feelisch, M., Busse, R., and Moncada, S. Portland Press, London, 1994, pp. 179–181.
Nava, E., Noll, G., and Löscher, T.F. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension.Circulation 912310–2313 (1995).
Nava, E., Moreau, P., Löscher, T.F. Basal production of nitric oxide is increased, but inefficacious in spontaneous hypertension.Circulation 92(8), I 347 (1995).
Hutcheson, R. and Griffith, T.M. Release of endothelium derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow.Am. J. Physiol. 30H257–H262 (1991).
Kanai, A.J., Strauss, H.C., Truskey, G.A., Crews, A.L., Grunfeld, S., and Malinski, T. Shear stress induces ATP independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor.Cir. Res. 77284–293 (1995).
Pohl, U., Herlan, K., Huang, A., and Bassenge, E. EDRF mediated shear induced dilation opposes myogenic vasoconstriction in small rabbit arteries.Am. J. Physiol. 261H2016–H2023 (1991).
Awolesi, M.A., Sessa, W.C., and Sumpio, B.E. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells.J. Clin. Invest. 961449–1454 (1995).
Kelm, M., Feelisch, M., Deussen, A., Strauer, B.E., and Scharader, J. Release of endothelium derived nitric oxide in relation to pressure and flow.Cardiovasc. Res. 25831–836 (1991).
Smith, T.L. and Hutchings, P.M. Central hemodynamics in the developmental stage of spontaneous hypertension in the unanesthesized rat.Hypertension 1(5), 508–517 (1979).
Nishiyama, K., Nishiyama, A., and Frohlich, E.D. Regional blood flow in normotensive and spontaneously hypertensive rats.Am. J. Physiol. 230(3), 691–698 (1976).
De Clerck, F., Beerens, M., Van Gorp, L., and Xhonneux R. Blood hyperviscosity in spontaneously hypertensive rats.Throm. Res. 18291–295 (1980).
Assreuy, J., Cunha, F.Q., Liew, F.Y., and Moncada, S. Feedback inhibition of nitric oxide synthase activity by nitric oxide.Br. J. Pharmacol. 108833–837 (1993).
Löscher, T.F. and Vanhoutte, P.M. Endothelium dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.Hypertension 8344–348 (1986).
Dohi, Y., Thiel, M.A., Buhler, F.R., and Lüscher, T.F. Activation of the endothelial t arginine pathway in pressurized mesenteric resistance arteries: effect of age and hypertension.Hypertension 15170–179 (1990).
Löscher, T.F. Endothelium derived nitric oxide: The endogenous nitrovasodilator in the human cardiovascular system.Eur. Heart. J. 12(Suppl. E), 2–11 (1991).
Tschudi, M.R., Criscione, L., and Lüscher, T.F. Effect of aging and hypertension on endothelial function of rat coronary arteries.J. Hyperten. 9164–165 (1991).
Moncada, S. Nitric oxide.J. Hyperten. 12(Suppl. 10), S35–S39 (1994).
Calver, A., Collier, J., Moncada, S., and Vallance, P.Effect of local intra arterial 1V°-monomethyl-t,-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal.J. Hyperten. 101025–1031 (1992).
Linder, L., Kiowski, W., Buhler, F.R., and Löscher, T.F.Indirect evidence for the release of endothelium derived relaxing factor in human forearm circulation in vivo: Blunted response in essential hypertension.Circulation 811762–1768 (1990).
Panza, J.A., Casino, P.R., Kilcoyne, C.M., and Quyyumi, A.A. Role of endothelium dependent vascular relaxation of patients with essential hypertension.Circulation 871468–1474 (1993).
Taddei, S., Virdis, A., Mattei, P., and Salvetti, A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension 21929–933 (1993).
Benjamin, N., Copland, M., and Smith, L.M. Reduced nitric oxide synthesis in essential hypertension.Endothelium3, s94 (1995).
Valiance, P., Patton, S., Bhagat, K., Macalister, R., Radomski, M., Moncada, S., Malinski, T. Direct measurement of nitric oxide in humans.Endothelium 3s81 (1995).
Diederich, D., Yang, Z., Buhler, F.R., and Löscher, T.F. Impaired endothelium dependent relaxations in hypertensive resistance arteries involve cyclooxigenase pathway.Am. J. Physiol. 258H445–H451 (1990).
Hayakawa, H., Hirata, Y., Suzuki, E., Sugimoto, T., Matsuoka, H., Kikuchi, K., Nagano, T., Hirobe, M., Sugimoto, T. Mechanisms for altered endothelium dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am.J. Physiol. 264H1535–H1541 (1993).
Lindop, G.B.M.Textbook of Hypertension.Ed. Swales, J.D. Blackwell Scientific Publications, London, 1994, pp. 663–669.
Grunfeld, S., Hamilton, C.A., Mesaros, S., McClain, S.W., Dominiczak, A.F., Bohr, D.F., and Malinski, T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats.Hypertension 26(Part 1), 854–857 (1995).
Lahera, V., Salom, M.G., Miranda Guardiola, F., Moncada, S., and Romero, J.C. Effects of N-nitro-L-arginine methyl ester on renal function and blood pressure.Am. J. Physiol. 261F1033–F1037 (1991).
Salazar, F.J., Pinilla, J.M., Lopez, F., Romero, J.C., and Quesada, T. Renal effects of prolonged synthesis inhibition of endothgeliun derived nitric oxide.Hypertension 2249–55 (1992).
Salazar, F.J., Alberola, A., Pinilla, J.M., Romero, J.C., Quesada, T Salt induced increase in arterial pressure during nitric oxide synthesis inhibition.Hypertension 20113–117 (1993).
Alberola, A., Pinilla, J.M., Quesda, T., Romero, J.C., Salom, M.G., and Salazar, F.J. Role of nitric oxide in mediating renal response to volume expansion.Hypertension 19780–784 (1992).
Nava, E., Gonzalez, J.D., Llinas, M.T., and Salazar, F.J. Relative importance of constitutive NO synthase in the rat kidney. Eur. J. Clin. Invest. (in press).
Sigmon, D.H. and Beierwaltes, W.H. Nitric oxide influences blood flow distribution in renovascular hypertension.Hypertension 23(1), I-34-I-39 (1994).
Valiance, P., Leone, A., Calver, A., Collier, J., and Moncada, S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.Lancet 329572–575 (1992).
Lockette, W., Otsuka, Y., and Carretero, O.A. The loss of endothelium-dependent vascular relaxation in hypertension.Hypertension 8(Suppl. II), II-61-II-66 (1986).
Löscher, T.F. and Vanhoutte, P.M. Mechanisms of altered endothelium dependent responses in hypertensive blood vessels. In: Relaxing and Contracting Factors: Humana Press Clifton New Jersey 1988 Ed.
Lüscher, T.F., Raij, L., and Vanhoutte, P.M. Endothelium dependent vascular responses in normotensive and hypertensive Dahl rats.Hypertension 9157–163 (1987).
Chen, P.Y. and Sanders, P.W. L Arginine abrogates salt sensitive hypertension in Dahl/Rapp rats.J. Clin. Invest. 881559–1567 (1991).
Chen, P.Y. and Sanders, P.W. Role of nitric oxide synthesis in salt sensitive hypertension in Dahl/Rapp rats.Hypertension 22812–818 (1993).
Voorde, J.V. and Leusen, I. Endothelium dependent and independent relaxation of aortic rings from hypertensive rats.Am. J. Physiol. 250H711–H717 (1986).
Otsuka, Y., Dipiero, A., Hirt, E., Brennaman, B., and Lockette, W. Vascular relaxation and cGMP in hypertension.Am. J. Physiol 254H163–H169 (1988).
Hayakawa, H., Hirata, Y., Suzuki, E., Kimura, K., Kikuchi, K., Nagano, T., Hirobe, M., and Omata, M. Long term administration of L-arginine improves nitric oxide release from kikney in deoxycorticosterone acetate salt hypertensive rats.Hypertension 23(1), 752–756 (1994).
Laurant, P., Demolombe, B., Berthelot, A. Dietary L-arginine attenuates blood pressure in mineralocorticoid salt hypertensive rats.Clin. Exp. Hyperten. 17(7), 1009–1024 (1995).
Anversa, P., Peng, L.I., Malhotra, A., Zhang, X., Herman, M.V., and Capasso, J. Effects of hypertension and coronary constriction on cardiac function, morphology, and contractile proteins in rats.Am. J. Physiol. 265713–725 (1993).
Kelm, M., Feelisch, M., Krebber, T., Motz, W., and Strauer, B.E. The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: Comparison of normotensive and spontaneously hypertensive rats.J. Cardiovasc. Pharmacol. 20183–186 (1992).
Dubey, R.K., Jackson, E.K., and Löscher, T.F. Nitric oxide inhibits angiotensin-IIinduced migration of rat aortic smooth muscle cell.J. Clin. Invest. 96141–149 (1995).
Gustafsson, S.E., Leone, A.M., Persson, M.G., Wiklund, N.P., and Moncada, S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans.Biochem. Biophys. Res. Commun. 181852–857 (1991).
Leone, A.M., Gustafsson, S.E., Francis, P.L., Persson, M.G., Wiklund, N.P., and Moncada, S. Nitric oxide is present in exhaled breath in humans: direct GC MS confirmation.Biochem. Biophys. Res. Commun. 201883–887 (1994).
Wiklund, N.P., Persson, M.G., Gustafsson, L.E., Moncada, S., and Hedqvist, P. Modulatory role of endogenous nitric oxide in pulmonary circulationin vivo. Eur. J. Pharmacol. 185123–124 (1990).
Landzberg, M.J., Graydon, E., Fernandes, S.M., Hare, J.M., Body, S.C., Atz, A.M., and Wessel, D.L. Inhaled nitric oxide in primary pulmonary hypertension the perfect pulmonary vasodilator.Circulation 92(8), I241 (1995).
Roberts, J.D., Polanger, D.M., Lang, P., and Zapol, W.M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.Lancet 340818–819 (1992).
Roberts, J.D., Lang, P., Bigatello, L.M., Vlahakes, G.J., and Zapol, W.M. Inhaled nitric oxide in congenital heart disease.Circulation 87447–453 (1993).
Pepke-Zaba, J., Higenbottam, T.X., Tuan Dinh-Xuan, A., Stone, D., and Wallwork, J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.Lancet 3381173–1174 (1991).
Blomqvist, H., Wickerts, C.J., Andreen, M., Ullberg, U., Ortqvist, A., and Frostell, C. Enhanced pneumonia resolution by inhalation of nitric oxide.Acta Anaesthesiol. Scand. 37110–114 (1993).
Adatia, I., Thomson, J., Landzberg, M., and Wessel, D. Inhaled nitric oxide in chronic obstructive lung disease.Lancet 341307–308 (1993).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nava, E., Noll, G., Lüscher, T.F. (1997). NO and Hypertension. In: Goligorsky, M.S., Gross, S.S. (eds) Nitric Oxide and the Kidney. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6039-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6039-5_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7768-9
Online ISBN: 978-1-4615-6039-5
eBook Packages: Springer Book Archive